|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:TTLL10-CTAG2 (FusionGDB2 ID:94488) |
Fusion Gene Summary for TTLL10-CTAG2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TTLL10-CTAG2 | Fusion gene ID: 94488 | Hgene | Tgene | Gene symbol | TTLL10 | CTAG2 | Gene ID | 254173 | 30848 |
| Gene name | tubulin tyrosine ligase like 10 | cancer/testis antigen 2 | |
| Synonyms | TTLL5 | CAMEL|CT2|CT6.2|CT6.2a|CT6.2b|ESO2|LAGE-1|LAGE2B | |
| Cytomap | 1p36.33 | Xq28 | |
| Type of gene | protein-coding | protein-coding | |
| Description | inactive polyglycylase TTLL10tubulin tyrosine ligase-like family, member 10tubulin tyrosine ligase-like family, member 5tubulin--tyrosine ligase-like protein 10 | cancer/testis antigen 2CTL-recognized antigen on melanomaLAGE-1a proteinautoimmunogenic cancer/testis antigen NY-ESO-2cancer/testis antigen 6.2cancer/testis antigen family 6, member 2acancer/testis antigen family 6, member 2bl antigen family member | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | O75638 | |
| Ensembl transtripts involved in fusion gene | ENST00000506177, ENST00000379290, ENST00000379289, ENST00000379288, | ENST00000247306, ENST00000369585, | |
| Fusion gene scores | * DoF score | 3 X 1 X 1=3 | 1 X 1 X 1=1 |
| # samples | 2 | 1 | |
| ** MAII score | log2(2/3*10)=2.73696559416621 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: TTLL10 [Title/Abstract] AND CTAG2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | TTLL10(1120489)-CTAG2(153880541), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | TTLL10 | GO:0018094 | protein polyglycylation | 19524510 |
| Fusion gene breakpoints across TTLL10 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across CTAG2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | CESC | TCGA-Q1-A73P-01A | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| ChimerDB4 | CESC | TCGA-Q1-A73P-01A | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
Top |
Fusion Gene ORF analysis for TTLL10-CTAG2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000506177 | ENST00000247306 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| intron-3CDS | ENST00000506177 | ENST00000369585 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| Frame-shift | ENST00000379290 | ENST00000247306 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| In-frame | ENST00000379290 | ENST00000369585 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| Frame-shift | ENST00000379289 | ENST00000247306 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| In-frame | ENST00000379289 | ENST00000369585 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| In-frame | ENST00000379288 | ENST00000247306 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| Frame-shift | ENST00000379288 | ENST00000369585 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000379290 | TTLL10 | chr1 | 1120489 | + | ENST00000369585 | CTAG2 | chrX | 153880541 | - | 1865 | 1574 | 95 | 1864 | 590 |
| ENST00000379289 | TTLL10 | chr1 | 1120489 | + | ENST00000369585 | CTAG2 | chrX | 153880541 | - | 1843 | 1552 | 73 | 1842 | 590 |
| ENST00000379288 | TTLL10 | chr1 | 1120489 | + | ENST00000247306 | CTAG2 | chrX | 153880541 | - | 2269 | 1973 | 75 | 1250 | 391 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000379290 | ENST00000369585 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - | 0.24073213 | 0.7592678 |
| ENST00000379289 | ENST00000369585 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - | 0.36659354 | 0.6334064 |
| ENST00000379288 | ENST00000247306 | TTLL10 | chr1 | 1120489 | + | CTAG2 | chrX | 153880541 | - | 0.030410929 | 0.96958905 |
Top |
Fusion Genomic Features for TTLL10-CTAG2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for TTLL10-CTAG2 |
| Go to FGviewer for the breakpoints of chr1:1120489-chrX:153880541 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | CTAG2 |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379289 | + | 13 | 16 | 362_365 | 467.0 | 674.0 | Nucleotide binding | ATP binding |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379290 | + | 13 | 16 | 362_365 | 467.0 | 674.0 | Nucleotide binding | ATP binding |
| Tgene | CTAG2 | chr1:1120489 | chrX:153880541 | ENST00000247306 | 0 | 2 | 183_188 | 0 | 211.0 | Compositional bias | Note=Poly-Pro | |
| Tgene | CTAG2 | chr1:1120489 | chrX:153880541 | ENST00000247306 | 0 | 2 | 5_79 | 0 | 211.0 | Compositional bias | Note=Gly-rich | |
| Tgene | CTAG2 | chr1:1120489 | chrX:153880541 | ENST00000369585 | 1 | 3 | 183_188 | 134.66666666666666 | 181.0 | Compositional bias | Note=Poly-Pro |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379288 | + | 1 | 9 | 586_627 | 0 | 405.0 | Compositional bias | Note=Pro-rich |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379289 | + | 13 | 16 | 586_627 | 467.0 | 674.0 | Compositional bias | Note=Pro-rich |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379290 | + | 13 | 16 | 586_627 | 467.0 | 674.0 | Compositional bias | Note=Pro-rich |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379288 | + | 1 | 9 | 155_552 | 0 | 405.0 | Domain | TTL |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379289 | + | 13 | 16 | 155_552 | 467.0 | 674.0 | Domain | TTL |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379290 | + | 13 | 16 | 155_552 | 467.0 | 674.0 | Domain | TTL |
| Hgene | TTLL10 | chr1:1120489 | chrX:153880541 | ENST00000379288 | + | 1 | 9 | 362_365 | 0 | 405.0 | Nucleotide binding | ATP binding |
| Tgene | CTAG2 | chr1:1120489 | chrX:153880541 | ENST00000369585 | 1 | 3 | 5_79 | 134.66666666666666 | 181.0 | Compositional bias | Note=Gly-rich |
Top |
Fusion Gene Sequence for TTLL10-CTAG2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000379290_ENST00000369585_TCGA-Q1-A73P-01A_TTLL10_chr1_1120489_+_CTAG2_chrX_153880541_length(transcript)=1865nt_BP=1574nt CCCAGGACCTTGTGGGCTGGGCAGGTCGTGCGTCCTTTGACAGCGGCCTCCGGCCGGGAGGCACCAGCTCTTCGAACAATGTTTAAAAGT CTCTTCTGTTCATCCTACCGGGGTGCCGTCTCCTGCCGGTCTTTTCATCTCACCAGGGCCCTCGCCCGGGCACCCCCCGGCCAATGGACC ACAGCTGCACCCGGTTCATCCACCGCCGGGGACCACCCACTCGGACCCGAGCCGGCTTCAAGAGGGGCAAGAGGCCAAGGATCCAGCAGA GGCCTCGGGCTCGAGTCTCAGGGACCATCCCTGCGTCACGTCTGCACCCAGCACCGGCCTCACAGCCCGGCCCCTGCCCTGCACCAGGCC ACTGCCCTGTTGGCCCGGCCCACGAGAGGCCAATGGGGAGCAGCCAGGAGGAGGGACTCCGGTGTCAGCCAAGCCAGCCAGACCACGACG CAGATGGACACTGTGGGCCGGACCTGGAGGGGGCAGAAAGAGCCTCTGCCACACCCGGACCCCCTGGGCTCCTGAACAGCCACCGGCCTG CAGACTCGGATGACACTAACGCCGCCGGGCCCTCAGCTGCCCTCCTGGAGGGGCTCCTGCTGGGGGGTGGGAAGCCATCGCCCCACAGCA CCCGGCCGGGGCCCTTCTTCTACATTGGAGGCAGCAACGGGGCCACAATCATCAGCTCCTACTGCAAAAGCAAGGGCTGGCAGCGCATCC ATGACAGCCGCCGGGACGACTACACGCTGAAGTGGTGTGAGGTCAAGAGCCGAGACAGCTACGGCAGCTTCCGGGAAGGAGAGCAGCTGC TGTACCAGCTTCCCAACAACAAGCTCCTCACCACCAAGATCGGGCTGCTCAGCACCCTTCGGGGACGGGCACGGGCCATGAGCAAGGCCA GCAAGGTGCCGGGGGGGGTCCAGGCCAGGCTGGAAAAGGACGCAGCAGCGCCCGCCCTGGAGGACCTCCCGTGGACAAGCCCAGGATACC TCAGGCCACAGAGGGTCCTGAGAATGGAAGAGTTTTTCCCAGAGACCTACCGCCTGGACCTCAAACACGAGAGAGAGGCCTTTTTCACCT TGTTTGATGAAACCCAGATATGGATCTGCAAGCCCACAGCCTCCAACCAGGGCAAAGGCATCTTCCTGCTCCGGAACCAGGAGGAAGTTG CCGCCCTGCAGGCCAAGACCCGGAGCATGGAGGACGACCCCATCCACCACAAGACGCCGTTCCGGGGGCCTCAGGCGCGGGTGGTGCAGA GGTACATCCAGAACCCGCTGCTGGTGGACGGGAGAAAGTTTGACGTGCGCTCCTACCTGCTCATTGCCTGCACCACACCCTACATGATCT TCTTTGGCCACGGCTATGCTCGCCTCACCCTTAGCCTTTACGACCCCCATTCCAGCGACCTCGGCGGCCACTTGACCAACCAGTTCATGC AGAAGAAGAGCCCTCTGTACATGCTGCTGAAGGAGCACACGGTGTGGAGCATGGAACACCTCAACCGCTACATCAGTGACACGTTCTGGA AGGCCCGGGGCCTCGCCAAGGACTGGGTCTTCACCACCCTCAAGCCGACTGACTGCTGCAGACCACCGCCAACTGCAGCTCTCCATCAGC TCCTGTCTCCAGCAGCTTTCCCTGTTGATGTGGATCACGCAGTGCTTTCTGCCCGTGTTTTTGGCTCAGGCTCCCTCAGGGCAGAGGCGC TAAGCCCAGCCTGGCGCCCCTTCCTAGGTCATGCCTCCTCCCCTAGGGAATGGTCCCAGCACGAGTGGCCAGTTCATTGTGGGGGCCTGA >In-frame_ENST00000379290_ENST00000369585_TCGA-Q1-A73P-01A_TTLL10_chr1_1120489_+_CTAG2_chrX_153880541_length(amino acids)=590AA_start in transcript=95_stop in transcript=1864 MFILPGCRLLPVFSSHQGPRPGTPRPMDHSCTRFIHRRGPPTRTRAGFKRGKRPRIQQRPRARVSGTIPASRLHPAPASQPGPCPAPGHC PVGPAHERPMGSSQEEGLRCQPSQPDHDADGHCGPDLEGAERASATPGPPGLLNSHRPADSDDTNAAGPSAALLEGLLLGGGKPSPHSTR PGPFFYIGGSNGATIISSYCKSKGWQRIHDSRRDDYTLKWCEVKSRDSYGSFREGEQLLYQLPNNKLLTTKIGLLSTLRGRARAMSKASK VPGGVQARLEKDAAAPALEDLPWTSPGYLRPQRVLRMEEFFPETYRLDLKHEREAFFTLFDETQIWICKPTASNQGKGIFLLRNQEEVAA LQAKTRSMEDDPIHHKTPFRGPQARVVQRYIQNPLLVDGRKFDVRSYLLIACTTPYMIFFGHGYARLTLSLYDPHSSDLGGHLTNQFMQK KSPLYMLLKEHTVWSMEHLNRYISDTFWKARGLAKDWVFTTLKPTDCCRPPPTAALHQLLSPAAFPVDVDHAVLSARVFGSGSLRAEALS -------------------------------------------------------------- >In-frame_ENST00000379289_ENST00000369585_TCGA-Q1-A73P-01A_TTLL10_chr1_1120489_+_CTAG2_chrX_153880541_length(transcript)=1843nt_BP=1552nt AGGACCTTGTGGGCTGGGCAGCGGCCTCCGGCCGGGAGGCACCAGCTCTTCGAACAATGTTTAAAAGTCTCTTCTGTTCATCCTACCGGG GTGCCGTCTCCTGCCGGTCTTTTCATCTCACCAGGGCCCTCGCCCGGGCACCCCCCGGCCAATGGACCACAGCTGCACCCGGTTCATCCA CCGCCGGGGACCACCCACTCGGACCCGAGCCGGCTTCAAGAGGGGCAAGAGGCCAAGGATCCAGCAGAGGCCTCGGGCTCGAGTCTCAGG GACCATCCCTGCGTCACGTCTGCACCCAGCACCGGCCTCACAGCCCGGCCCCTGCCCTGCACCAGGCCACTGCCCTGTTGGCCCGGCCCA CGAGAGGCCAATGGGGAGCAGCCAGGAGGAGGGACTCCGGTGTCAGCCAAGCCAGCCAGACCACGACGCAGATGGACACTGTGGGCCGGA CCTGGAGGGGGCAGAAAGAGCCTCTGCCACACCCGGACCCCCTGGGCTCCTGAACAGCCACCGGCCTGCAGACTCGGATGACACTAACGC CGCCGGGCCCTCAGCTGCCCTCCTGGAGGGGCTCCTGCTGGGGGGTGGGAAGCCATCGCCCCACAGCACCCGGCCGGGGCCCTTCTTCTA CATTGGAGGCAGCAACGGGGCCACAATCATCAGCTCCTACTGCAAAAGCAAGGGCTGGCAGCGCATCCATGACAGCCGCCGGGACGACTA CACGCTGAAGTGGTGTGAGGTCAAGAGCCGAGACAGCTACGGCAGCTTCCGGGAAGGAGAGCAGCTGCTGTACCAGCTTCCCAACAACAA GCTCCTCACCACCAAGATCGGGCTGCTCAGCACCCTTCGGGGACGGGCACGGGCCATGAGCAAGGCCAGCAAGGTGCCGGGGGGGGTCCA GGCCAGGCTGGAAAAGGACGCAGCAGCGCCCGCCCTGGAGGACCTCCCGTGGACAAGCCCAGGATACCTCAGGCCACAGAGGGTCCTGAG AATGGAAGAGTTTTTCCCAGAGACCTACCGCCTGGACCTCAAACACGAGAGAGAGGCCTTTTTCACCTTGTTTGATGAAACCCAGATATG GATCTGCAAGCCCACAGCCTCCAACCAGGGCAAAGGCATCTTCCTGCTCCGGAACCAGGAGGAAGTTGCCGCCCTGCAGGCCAAGACCCG GAGCATGGAGGACGACCCCATCCACCACAAGACGCCGTTCCGGGGGCCTCAGGCGCGGGTGGTGCAGAGGTACATCCAGAACCCGCTGCT GGTGGACGGGAGAAAGTTTGACGTGCGCTCCTACCTGCTCATTGCCTGCACCACACCCTACATGATCTTCTTTGGCCACGGCTATGCTCG CCTCACCCTTAGCCTTTACGACCCCCATTCCAGCGACCTCGGCGGCCACTTGACCAACCAGTTCATGCAGAAGAAGAGCCCTCTGTACAT GCTGCTGAAGGAGCACACGGTGTGGAGCATGGAACACCTCAACCGCTACATCAGTGACACGTTCTGGAAGGCCCGGGGCCTCGCCAAGGA CTGGGTCTTCACCACCCTCAAGCCGACTGACTGCTGCAGACCACCGCCAACTGCAGCTCTCCATCAGCTCCTGTCTCCAGCAGCTTTCCC TGTTGATGTGGATCACGCAGTGCTTTCTGCCCGTGTTTTTGGCTCAGGCTCCCTCAGGGCAGAGGCGCTAAGCCCAGCCTGGCGCCCCTT CCTAGGTCATGCCTCCTCCCCTAGGGAATGGTCCCAGCACGAGTGGCCAGTTCATTGTGGGGGCCTGATTGTTTGTCGCTGGAGGAGGAC >In-frame_ENST00000379289_ENST00000369585_TCGA-Q1-A73P-01A_TTLL10_chr1_1120489_+_CTAG2_chrX_153880541_length(amino acids)=590AA_start in transcript=73_stop in transcript=1842 MFILPGCRLLPVFSSHQGPRPGTPRPMDHSCTRFIHRRGPPTRTRAGFKRGKRPRIQQRPRARVSGTIPASRLHPAPASQPGPCPAPGHC PVGPAHERPMGSSQEEGLRCQPSQPDHDADGHCGPDLEGAERASATPGPPGLLNSHRPADSDDTNAAGPSAALLEGLLLGGGKPSPHSTR PGPFFYIGGSNGATIISSYCKSKGWQRIHDSRRDDYTLKWCEVKSRDSYGSFREGEQLLYQLPNNKLLTTKIGLLSTLRGRARAMSKASK VPGGVQARLEKDAAAPALEDLPWTSPGYLRPQRVLRMEEFFPETYRLDLKHEREAFFTLFDETQIWICKPTASNQGKGIFLLRNQEEVAA LQAKTRSMEDDPIHHKTPFRGPQARVVQRYIQNPLLVDGRKFDVRSYLLIACTTPYMIFFGHGYARLTLSLYDPHSSDLGGHLTNQFMQK KSPLYMLLKEHTVWSMEHLNRYISDTFWKARGLAKDWVFTTLKPTDCCRPPPTAALHQLLSPAAFPVDVDHAVLSARVFGSGSLRAEALS -------------------------------------------------------------- >In-frame_ENST00000379288_ENST00000247306_TCGA-Q1-A73P-01A_TTLL10_chr1_1120489_+_CTAG2_chrX_153880541_length(transcript)=2269nt_BP=1973nt ACAGCCCGGCCCCTGCCCTGCACCAGGCCACTGCCCTGTTGGTGAGGAGGGTCGGAGGGGCGACCTCCCTGCCCCCTGCTCCAAGCTCCC CACCCCCACCTGGAACCTGCCGGCAGGAAGCCTGGCCCTGGAGGGTGGTCACGGCCCCTCCCCAGATGCCCGGCCCACGAGAGGCCAATG GGGAGCAGCCAGGAGGAGGGACTCCGGTGTCAGCCAAGCCAGCCAGACCACGACGCAGATGGACACTGTGGGCCGGACCTGGAGGGGGCA GAAAGAGCCTCTGCCACACCCGGACCCCCTGGGCTCCTGAACAGCCACCGGCCTGCAGACTCGGATGACACTAACGCCGCCGGGCCCTCA GCTGCCCTCCTGGAGGGGCTCCTGCTGGGGGGTGGGAAGCCATCGCCCCACAGCACCCGGCCGGGGCCCTTCTTCTACATTGGAGGCAGC AACGGGGCCACAATCATCAGCTCCTACTGCAAAAGCAAGGGCTGGCAGCGCATCCATGACAGCCGCCGGGACGACTACACGCTGAAGTGG TGTGAGGTCAAGAGCCGAGACAGCTACGGCAGCTTCCGGGAAGGAGAGCAGCTGCTGTACCAGCTTCCCAACAACAAGCTCCTCACCACC AAGATCGGGCTGCTCAGCACCCTTCGGGGACGGGCACGGGCCATGAGCAAGGCCAGCAAGGTGCCGGGGGGGGTCCAGGCCAGGCTGGAA AAGGACGCAGCAGCGCCCGCCCTGGAGGACCTCCCGTGGACAAGCCCAGGATACCTCAGGCCACAGAGGGTCCTGAGAATGGAAGAGTTT TTCCCAGAGACCTACCGCCTGGACCTCAAACACGAGAGAGAGGCCTTTTTCACCTTGTTTGATGAAACCCAGATATGGATCTGCAAGCCC ACAGCCTCCAACCAGGGCAAAGGCATCTTCCTGCTCCGGAACCAGGAGGAAGTTGCCGCCCTGCAGGCCAAGACCCGGAGCATGGAGGAC GACCCCATCCACCACAAGACGCCGTTCCGGGGGCCTCAGGCGCGGGTGGTGCAGAGGTACATCCAGAACCCGCTGCTGGTGGACGGGAGA AAGTTTGACGTGCGCTCCTACCTGCTCATTGCCTGCACCACACCCTACATGATCTTCTTTGGCCACGGCTATGCTCGCCTCACCCTTAGC CTTTACGACCCCCATTCCAGCGACCTCGGCGGCCACTTGACCAACCAGGTGCGTCCACTGTGCCCTCCAGTCTGGGAGTGAGATCCCTCG GGGCGGGGGTGTGTGGTCAGGCTGGGCACCAGGCACACAGATGTCCGTGGCGTGCGTGGGCGGCTGCGCTGAAGTGTGACCTGACCGTGT GGAACCAAACCCTTCCAGCGTCTCTGCTCACTTAGCTGGCAGTGCCTGTCCCCAGCAGCCAGCAAAGGCCCGGACGGAAAGCCCAGTCGG GGGTCTGTCGGCACGAGTCCCGCGGGCAGCCTCGCCGTAGGGTCAGGGGACAGCTCGGCTTCAGTGACAGCCACCATGTGAAGAGTCTTT GTTCCTTTCAGATCCTCCACTTGGCAGGCAGGGCCAACAGCAGCCCCCGGGCCAGGTGTCCTGGAGCAGCAGCAGCTGCCCGTGCAGGCC CGGACTCTCCCTAGCTAAGGGCCATGTGCGGTGGAGTGTCCTAATTTTGCAGGGTTCCTTTCTGTGGGGGTACCTGTGGGGTACTTCAAA CAGCCCTAGCAGCAAAGGCCCTTGAGCAGCGCGGTGTGAAACTGGGATAAAAACGGGGCTTGGCCGAAGGACTTTTATCTGTCTTGGTCA CCCCGGCCAGGCCCCGGAAGCAGCAGCCAGGGATGGTCCTTCCTCACCCACAGGCGTGTGTCACTGTGGCTGGGACGGCAGCGCTCAGAG GAGCCTCCAGTTACTTTCCTCACATCTCCCAAACTCTCTCTTAATTGCGATAATTCACAGAACATAAAATTCACGATCTTAAACCGACTG ACTGCTGCAGACCACCGCCAACTGCAGCTCTCCATCAGCTCCTGTCTCCAGCAGCTTTCCCTGTTGATGTGGATCACGCAGTGCTTTCTG CCCGTGTTTTTGGCTCAGGCTCCCTCAGGGCAGAGGCGCTAAGCCCAGCCTGGCGCCCCTTCCTAGGTCATGCCTCCTCCCCTAGGGAAT GGTCCCAGCACGAGTGGCCAGTTCATTGTGGGGGCCTGATTGTTTGTCGCTGGAGGAGGACGGCTTACATGTTTGTTTCTGTAGAAAATA >In-frame_ENST00000379288_ENST00000247306_TCGA-Q1-A73P-01A_TTLL10_chr1_1120489_+_CTAG2_chrX_153880541_length(amino acids)=391AA_start in transcript=75_stop in transcript=1250 MLQAPHPHLEPAGRKPGPGGWSRPLPRCPAHERPMGSSQEEGLRCQPSQPDHDADGHCGPDLEGAERASATPGPPGLLNSHRPADSDDTN AAGPSAALLEGLLLGGGKPSPHSTRPGPFFYIGGSNGATIISSYCKSKGWQRIHDSRRDDYTLKWCEVKSRDSYGSFREGEQLLYQLPNN KLLTTKIGLLSTLRGRARAMSKASKVPGGVQARLEKDAAAPALEDLPWTSPGYLRPQRVLRMEEFFPETYRLDLKHEREAFFTLFDETQI WICKPTASNQGKGIFLLRNQEEVAALQAKTRSMEDDPIHHKTPFRGPQARVVQRYIQNPLLVDGRKFDVRSYLLIACTTPYMIFFGHGYA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for TTLL10-CTAG2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for TTLL10-CTAG2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for TTLL10-CTAG2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies